Plant ID: NPO3291
Plant Latin Name: Cynanchum auriculatum
Taxonomy Genus: Cynanchum
Taxonomy Family: Apocynaceae
NCBI TaxonomyDB:
157409
Plant-of-the-World-Online:
n.a.
Cytochrome P450 Enzymes: |
---|
Protein Class | Gene ID | Protein Name | Uniprot ID | Target ChEMBL ID |
---|---|---|---|---|
Enzyme_unclassified | PTGES | Prostaglandin E synthase | O14684 | CHEMBL5658 |
Enzyme_unclassified | HSD11B1 | 11-beta-hydroxysteroid dehydrogenase 1 | P28845 | CHEMBL4235 |
Protein Phosphatase | PTPN1 | Protein-tyrosine phosphatase 1B | P18031 | CHEMBL335 |
GO Type | GO Category | Enriched GO Terms | p-Value | Adjusted p-Value | Enriched Genes |
---|---|---|---|---|---|
BP | GO:0009987; cellular process | GO:1902202; regulation of hepatocyte growth factor receptor signaling pathway | 6.212E-04 | 1.000E+00 | PTPN1 |
BP | GO:0009987; cellular process | GO:0035791; platelet-derived growth factor receptor-beta signaling pathway | 9.316E-04 | 1.000E+00 | PTPN1 |
BP | GO:0008152; metabolic process | GO:0019371; cyclooxygenase pathway | 1.708E-03 | 1.000E+00 | PTGES |
BP | GO:0050896; response to stimulus | GO:0060397; JAK-STAT cascade involved in growth hormone signaling pathway | 2.328E-03 | 1.000E+00 | PTPN1 |
BP | GO:0050896; response to stimulus | GO:0046627; negative regulation of insulin receptor signaling pathway | 4.652E-03 | 1.000E+00 | PTPN1 |
BP | Unclassified; | GO:0061098; positive regulation of protein tyrosine kinase activity | 6.664E-03 | 1.000E+00 | PTPN1 |
BP | GO:0009987; cellular process | GO:0060338; regulation of type I interferon-mediated signaling pathway | 7.128E-03 | 1.000E+00 | PTPN1 |
BP | GO:0032501; multicellular organismal process | GO:0030324; lung development | 1.176E-02 | 1.000E+00 | HSD11B1 |
BP | GO:0051179; localization | GO:0030100; regulation of endocytosis | 3.363E-02 | 1.000E+00 | PTPN1 |
BP | GO:0050896; response to stimulus | GO:0032496; response to lipopolysaccharide | 4.241E-02 | 1.000E+00 | PTGES |
CC | GO:0044464; cell part | GO:0097443; sorting endosome | 9.316E-04 | 1.000E+00 | PTPN1 |
CC | GO:0044464; cell part | GO:0005641; nuclear envelope lumen | 1.242E-03 | 1.000E+00 | PTGES |
MF | GO:0005488; binding | GO:0051721; protein phosphatase 2A binding | 4.343E-03 | 1.000E+00 | PTPN1 |
MF | GO:0005488; binding | GO:0030971; receptor tyrosine kinase binding | 8.673E-03 | 1.000E+00 | PTPN1 |
MF | GO:0003824; catalytic activity | GO:0004725; protein tyrosine phosphatase activity | 1.576E-02 | 1.000E+00 | PTPN1 |
Pathway Category Top Level | Pathway Category Second Level | Pathway ID | Pathway Name | p-Value | Adjusted p-Value | Enriched Genes |
---|---|---|---|---|---|---|
09100 Metabolism | 09103 Lipid metabolism | hsa00590 | Arachidonic acid metabolism | 9.272E-03 | 1.633E-02 | PTGES |
Unclassified | Unclassified | hsa01100 | Metabolic pathways | 1.103E-02 | 1.633E-02 | HSD11B1, PTGES |
09100 Metabolism | 09103 Lipid metabolism | hsa00140 | Steroid hormone biosynthesis | 8.675E-03 | 1.633E-02 | HSD11B1 |
09100 Metabolism | 09111 Xenobiotics biodegradation and metabolism | hsa00980 | Metabolism of xenobiotics by cytochrome P450 | 1.091E-02 | 1.633E-02 | HSD11B1 |
09140 Cellular Processes | 09144 Cellular community - eukaryotes | hsa04520 | Adherens junction | 1.106E-02 | 1.633E-02 | PTPN1 |
09160 Human Diseases | 09166 Endocrine and metabolic diseases | hsa04931 | Insulin resistance | 1.626E-02 | 1.858E-02 | PTPN1 |
09160 Human Diseases | 09161 Cancers | hsa05204 | Chemical carcinogenesis | 1.225E-02 | 1.633E-02 | HSD11B1 |
09150 Organismal Systems | 09152 Endocrine system | hsa04910 | Insulin signaling pathway | 2.071E-02 | 2.071E-02 | PTPN1 |
ICD10 Disease Category | Disease Name | ICD10 Code | Associated Disease Targets (Association Ref: TTD database) |
---|---|---|---|
E00-E89: Endocrine, nutritional and metabolic diseases | Type 2 diabetes | E11 | HSD11B1; |
H00-H59: Diseases of the eye and adnexa | Ocular hypertension | H40.0 | HSD11B1; |
E00-E89: Endocrine, nutritional and metabolic diseases | Metabolic disorders | E70-E89 | HSD11B1; |
E00-E89: Endocrine, nutritional and metabolic diseases | Obesity | E66 | HSD11B1; |
E00-E89: Endocrine, nutritional and metabolic diseases | Non-insulin dependent diabetes | E11.9 | HSD11B1; |
J00-J99: Diseases of the respiratory system | Influenza virus | J11.1 | HSD11B1; |
E00-E89: Endocrine, nutritional and metabolic diseases | Diabetes | E23.2, N25.1 | HSD11B1; |
E00-E89: Endocrine, nutritional and metabolic diseases | Hypercholesterolemia | E78 | HSD11B1; |
I00-I99: Diseases of the circulatory system | Atherosclerosis | I70 | HSD11B1; |
E00-E89: Endocrine, nutritional and metabolic diseases | Lipid metabolism disorder | E75-E78 | HSD11B1; |
E00-E89: Endocrine, nutritional and metabolic diseases | Metabolic syndrome x | E88.81 | HSD11B1; |